Pre-exposure prophylaxis (PrEP) is an effective tool for preventing human immunodeficiency virus (HIV) acquisition in sexually active at-risk individuals such as men who have sex with men (MSM). The purpose of this study is to examine factors associated with intent to engage in risky sexual behavior among HIV-negative college aged (18-24) MSM who are currently adherent to PrEP or who have expressed interest in the future adoption of PrEP. A multiracial/ethnic sample of 31 men expressing interest in the adoption of PrEP and 6 men currently taking PrEP completed a quantitative survey identifying key themes regarding attitudes towards PrEP and potential behaviors associated with adherence. Themes associated with current adherence to PrEP inclu...
Introduction HIV pre-exposure prophylaxis (PrEP) involves the use of antiretroviral medication in H...
HIV transmission continues to increase for Gay men, especially for those Gay men in nonmonogamous se...
BACKGROUND: Pre-exposure prophylaxis (PrEP) can significantly reduce HIV acquisition especially amon...
Prevention is key to keeping men who have sex with men (MSM) protected from Human Immunodeficiency V...
HIV is an infectious disease that continues to have new cases each year within high-risk populations...
In 2012, the first pharmacological HIV preventative agent, pre-exposure prophylaxis (PrEP) was appro...
In 2012, the US Food and Drug Administration approved the pill Truvada for use as pre-exposure proph...
Recent multicenter, randomized, double blind clinical trials have shown no association between HIV p...
HIV pre-exposure prophylaxis (PrEP) medication is 99% effective at preventing HIV acquisition if use...
BACKGROUND: HIV pre-exposure prophylaxis (PrEP) is a prescription antiretroviral medication that an ...
The HPTN 067/Alternative Dosing to Augment Pre-Exposure Prophylaxis Pill Taking (ADAPT) study evalua...
Background - Pre-exposure prophylaxis (PrEP) provides protection against HIV transmission but not ag...
In the absence of an effective vaccine, the introduction of pre-exposure prophylaxis (PrEP) in 2012 ...
Pre-exposure prophylaxis (PrEP) is an evidence-based new biomedical HIV prevention intervention, whi...
PrEP (Pre-Exposure Prophylaxis), which appeared on the market after FDA approval in 2012, is more th...
Introduction HIV pre-exposure prophylaxis (PrEP) involves the use of antiretroviral medication in H...
HIV transmission continues to increase for Gay men, especially for those Gay men in nonmonogamous se...
BACKGROUND: Pre-exposure prophylaxis (PrEP) can significantly reduce HIV acquisition especially amon...
Prevention is key to keeping men who have sex with men (MSM) protected from Human Immunodeficiency V...
HIV is an infectious disease that continues to have new cases each year within high-risk populations...
In 2012, the first pharmacological HIV preventative agent, pre-exposure prophylaxis (PrEP) was appro...
In 2012, the US Food and Drug Administration approved the pill Truvada for use as pre-exposure proph...
Recent multicenter, randomized, double blind clinical trials have shown no association between HIV p...
HIV pre-exposure prophylaxis (PrEP) medication is 99% effective at preventing HIV acquisition if use...
BACKGROUND: HIV pre-exposure prophylaxis (PrEP) is a prescription antiretroviral medication that an ...
The HPTN 067/Alternative Dosing to Augment Pre-Exposure Prophylaxis Pill Taking (ADAPT) study evalua...
Background - Pre-exposure prophylaxis (PrEP) provides protection against HIV transmission but not ag...
In the absence of an effective vaccine, the introduction of pre-exposure prophylaxis (PrEP) in 2012 ...
Pre-exposure prophylaxis (PrEP) is an evidence-based new biomedical HIV prevention intervention, whi...
PrEP (Pre-Exposure Prophylaxis), which appeared on the market after FDA approval in 2012, is more th...
Introduction HIV pre-exposure prophylaxis (PrEP) involves the use of antiretroviral medication in H...
HIV transmission continues to increase for Gay men, especially for those Gay men in nonmonogamous se...
BACKGROUND: Pre-exposure prophylaxis (PrEP) can significantly reduce HIV acquisition especially amon...